Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | -3.26% | -2.20% | +28.99% |
17/05 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
15/05 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.99% | 351M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Receives Positive Feedback From European Medicines Agency About Efti to Treat Brain Cancer